Gallbladder Ejection Fraction Is Unrelated to Gallbladder Pathology in Children and Adolescents

Patrick M Jones1, Marc B Rosenman, Marian D Pfefferkorn

  • 1*Bronson Pediatric Gastroenterology, Bronson Children's Hospital, Kalamazoo, Michigan†Section of Children's Health Services Research‡Section of Pediatric and Adolescent Comparative Effectiveness Research, Department of Pediatrics§Section of Pediatric Surgery, Department of Surgery||Regenstrief Institute, Indiana University School of Medicine, Indianapolis.

Insights

Gallbladder ejection fraction (GBEF) from HIDA scans does not predict gallbladder pathology in children. This finding suggests caution when interpreting HIDA scan results for pediatric patients with biliary dyskinesia.

Area of Science:

  • Pediatric Gastroenterology
  • Diagnostic Imaging
  • Hepatobiliary System

Background:

  • Biliary dyskinesia is often diagnosed using gallbladder ejection fraction (GBEF) <35% in adults, leading to cholecystectomy.
  • This disorder is poorly characterized in pediatric populations.
  • Hepatic iminodiacetic acid (HIDA) scans are used to assess gallbladder function.

Purpose of the Study:

  • To investigate the relationship between GBEF and gallbladder pathology in patients aged 21 years and younger.
  • To determine if GBEF is a reliable predictor of gallbladder disease in children and adolescents.

Main Methods:

  • Retrospective analysis of HIDA scan and gallbladder pathology reports from a statewide medical record repository (2004-2013).
  • Data mining techniques were used to extract GBEF results.
  • Mixed effects logistic regression was employed to analyze the correlation between GBEF, patient demographics, and gallbladder pathology (cholecystitis, cholelithiasis, cholesterolosis).

Main Results:

  • A total of 2,841 HIDA scans from 2,558 patients were analyzed.
  • 310 patients had both HIDA scan and gallbladder pathology reports.
  • GBEF did not correlate with the presence of gallbladder pathology after controlling for demographic factors and pathologist.

Conclusions:

  • Hypokinetic gallbladders (low GBEF) are not more likely to have associated gallbladder pathology in pediatric patients.
  • Clinical interpretation of HIDA scan results in children and adolescents requires careful consideration.
  • The study highlights a potential disconnect between HIDA scan findings and histopathological evidence of disease in younger populations.
Abstract

Related Concept Videos

Gallbladder01:17

Gallbladder

The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
3.1K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373